1 / 17

Respiratory Distress Syndrome Treatment Market Analysis | Coherent Market Insights

Read here the market research report on u201cRespiratory Distress Syndrome Treatment Marketu201d by CMI team.

athiranair23
Download Presentation

Respiratory Distress Syndrome Treatment Market Analysis | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market InsightS Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. Neonatal & Preterm Infants Enteral Devices Market Analysis (2020-2027) • Enteral nutrition, also known as tube feeding, is a technique to deliver nutrients through a tube, if a patient cannot swallow. • Depending on the entry point of the tube in the body, enteral nutrition is classified in the following ways: nasogastric tube and gastrostomy or Percutaneous Endoscopic Gastrostomy (PEG) tube. • Statistics: The global neonatal and preterm infants enteral feeding devices market is estimated to account for US$ 4,026.7 Mn in terms of value by the end of 2027.

  3. Global Neonatal and Preterm Infants Enteral Feeding Devices Market: Drivers • Increasing preterm birth rate is expected to propel growth of the global neonatal and preterm infants enteral feeding devices market over the forecast period. For instance, according to March of Dimes 2019 report card, the preterm birth rate in the U.S. reached 10.02% in 2018 from 9.63% in 2015. • Moreover, increasing prevalence of chronic disorders in infants is also expected to aid in growth of the market. For instance, according to the study, ‘Prevalence of Pediatric Metabolic Syndrome and Associated Risk Factors among School-Age Children of 10–16 Years Living in District Shimla, Himachal Pradesh, India’, published in Indian Journal of Endocrinology and Metabolism in May 2018, the prevalence of pediatric metabolic syndrome was 3.3% and school-age children with high family monthly income and sedentary lifestyle were at high risk of the disease.

  4. s Statistics: North America held dominant position in the global neonatal and preterm infants enteral feeding devices market in 2019, accounting for 35.2% share in terms of value, followed by Europe and Asia Pacific, respectively.

  5. Figure 1: Global Neonatal and Preterm Infants Enteral Feeding Devices Market Share (%) Value, By Region, 2019

  6. Global Neonatal and Preterm Infants Enteral Feeding Devices Market: Restraints • Complications associated with enteral feeding are expected to hinder growth of the market. These complications include, nausea, vomiting, diarrhea, malabsorption, pulmonary aspiration, tube malposition, and tube clogging. • Moreover, bacterial contamination of enteral feed is also expected to limit growth of the market.

  7. Moreover, in Europe, according to National Library of Medicine, in 2017 the incidence of respiratory distress syndrome was 17.9 in 100,000 person population. After North America, Europe is the second region with highest mortality due to respiratory distress syndrome. • Moreover, Europe is also affected negatively due to COVID-19 pandemic, as coronavirus infection is accompanied with respiratory distress symptoms in severe cases. Therefore, pharmaceutical companies are focusing on research and development to find efficient dose regime against SARS-COVID- acute respiratory distress syndrome. For instance, in May 2020 ChiesiFarmaceutici S.P.A started clinical trial on Curosurf for treatment of SARS-COVID- acute respiratory distress syndrome. • Furthermore, Asia Pacific is expected to witness significant growth in the respiratory distress syndrome treatment market

  8. Asia Pacific region is less aware about respiratory distress syndrome but the prevalence of respiratory distress syndrome is moderate. • According National Library of Medicine, in 2017 incidence of respiratory distress syndrome in Asia Pacific was 3.04 in 100,000 person. • Therefore, pharmaceutical companies are focusing on research and development to achieve growth in the global respiratory distress syndrome market. • For instance, in 2018, JW pharmaceuticals, a South Korean company, started marketing ‘infasurf’, which is a drug treatment used for neonatal respiratory distress syndrome.

  9. Global Respiratory Distress Syndrome Treatment Market - Competitive Landscape Key players operating in the global respiratory distress syndrome treatment market include ChiesiFarmaceutici S.P.A, JW pharmaceuticals, Windtree Therapeutics, Inc, Ony Biotech Inc, AbbVie (NYSE: ABBV), Dey Laboratories Inc , and others.

  10. Key Developments: • In January 2020, ChiesiFarmaceuticiS.p.A began clinical trial study of administering surfactant (CUROSURF)in neonates, that will decrease the number of days that infant needs in breathing tube on mechanical ventilator suffering from respiratory distress syndrome • In April 2020, Citus Pharmaceutical Inc announced pre-IND submission to the U.S. Food Drug Administration under Coronavirus Treatment Accelerating Program for Novacite-cells therapy for acute respiratory distress syndrome in COVID-19 • In April 2020, ApepticoForschung und Entwicklung GmbH and OPIS srl announced that the solnatide IMP was approved for patients suffering from COVID-19 accompanied with pulmonary permeability oedema and acute respiratory distress syndrome (ARDS) by the Italian Medicines Agency and the Ethics Committee of the National Institute for Infectious Diseases LazzaroSpallanzani.

  11. Global Respiratory Distress Syndrome Treatment Market - Taxonomy • By Treatment Type • Surfactant Replacement Therapy • Continuous Positive Air Pressure (CPAP) • Positive End Expiratory Pressure (PEEP) • Antenatal Glucocorticoids • Others

  12. By Disease Type • Adult Respiratory Distress Syndrome • Neonatal Respiratory Distress Syndrome • By End User • Ambulatory Surgical Centers • Clinics • Hospitals • By Region • North America • Latin America • Europe • Asia Pacific • Middle East • Africa

  13. Request sample copy here Request PDF brochure here Request Customization here Talk to Analyst Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/neonatal-and-preterm-infants-enteral-feeding-devices-market-4078

  14. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  15. Contact Us: • Mr. Shah • Coherent Market Insights Pvt. Ltd. • Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S. • Phone: +1-206-701-6702 • Email :sales@coherentmarketinsights.com

  16. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related